BrightGene Bio-Medical Technology

BrightGene Bio-Medical Technology (Suzhou) Co., Ltd. is a research-driven high-tech pharmaceutical company, committed to the research, development, and production of innovative new drugs and high-end generics, providing patients with products of outstanding value through professional drug development and commercialization capabilities.
BrightGene aims to "innovate continuously and safeguard health," seeking solutions for unmet clinical needs. After years of sustained research and exploration, BrightGene has made breakthroughs in targeted therapy and immunotherapy for tumors, as well as in the treatment of fatty liver disease and diabetes, with multiple original innovative drugs entering or about to enter clinical studies. BrightGene has successfully developed high-end generics such as Eribulin, Trabectedin, and Fondaparinux Sodium, establishing a product line with global competitive advantages in areas such as anti-tumor, super antibiotics, and intravenous iron supplementation.
With strong R&D capabilities as its cornerstone, and relying on global registration and commercialization capabilities, as well as a cGMP production quality system aligned with international standards, BrightGene has achieved rapid development and has become a leading enterprise and international pioneer in China's pharmaceutical industry.
BrightGene's cGMP production quality system has passed official certifications from multiple countries and regions, including the US FDA, EU GMP, Japan PMDA, and Korea KFDA, as well as domestic new GMP certification, ensuring drug quality through international-standard pharmaceutical quality management norms and a rigorous drug production quality management system. The company's products are now marketed in numerous countries and regions worldwide, with major products holding significant market shares. We look forward to more collaborations with industry partners to achieve win-win outcomes and benefit patients globally.
BrightGene adheres to a "people-oriented" approach, providing broad development opportunities for various talents, offering patients high-quality, effective, safe, and reliable cost-effective medications, and creating a warm and healthy social environment. Rooted in China and with a global vision, BrightGene strives to build a more internationally competitive high-tech pharmaceutical enterprise integrating R&D, production, technical services, and sales.